DK0487575T3 - Farmaceutiske formuleringer - Google Patents

Farmaceutiske formuleringer

Info

Publication number
DK0487575T3
DK0487575T3 DK90912234.3T DK90912234T DK0487575T3 DK 0487575 T3 DK0487575 T3 DK 0487575T3 DK 90912234 T DK90912234 T DK 90912234T DK 0487575 T3 DK0487575 T3 DK 0487575T3
Authority
DK
Denmark
Prior art keywords
fat
soluble
gelatin capsules
hard gelatin
optionally
Prior art date
Application number
DK90912234.3T
Other languages
Danish (da)
English (en)
Inventor
Michael John Story
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898918809A external-priority patent/GB8918809D0/en
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Application granted granted Critical
Publication of DK0487575T3 publication Critical patent/DK0487575T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
DK90912234.3T 1989-08-17 1990-08-17 Farmaceutiske formuleringer DK0487575T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898918809A GB8918809D0 (en) 1989-08-17 1989-08-17 Pharmaceutical formulations
US08/430,500 US5738871A (en) 1989-08-17 1995-04-28 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DK0487575T3 true DK0487575T3 (da) 1994-11-28

Family

ID=26295779

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90912234.3T DK0487575T3 (da) 1989-08-17 1990-08-17 Farmaceutiske formuleringer

Country Status (13)

Country Link
US (1) US5738871A (fr)
EP (1) EP0487575B1 (fr)
JP (1) JPH04507418A (fr)
AT (1) ATE113471T1 (fr)
AU (1) AU633959B2 (fr)
CA (1) CA2063791C (fr)
DE (1) DE69013923T2 (fr)
DK (1) DK0487575T3 (fr)
ES (1) ES2062543T3 (fr)
FI (1) FI920646A0 (fr)
HK (1) HK85196A (fr)
NO (1) NO302333B1 (fr)
WO (1) WO1991002520A1 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
ES2308955T5 (es) * 1993-09-28 2012-04-03 R.P. Scherer Gmbh Fabricación de cápsulas de gelatina blanda
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JP2000501131A (ja) * 1995-11-24 2000-02-02 ロダース・クロックラーン・ビー・ブイ 魚油をベースとする組成物
US6056971A (en) * 1996-07-24 2000-05-02 Biosytes Usa, Inc. Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AUPP022297A0 (en) * 1997-11-06 1997-11-27 R.P. Scherer Holdings Pty Ltd Vitamin coating
TW367247B (en) * 1998-02-03 1999-08-21 Otsuka Pharma Co Ltd Storage container for Vitamin D solution and transfusion container
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
US6346231B1 (en) * 1999-10-06 2002-02-12 Joar Opheim Flavored gelatin capsule and method of manufacture
US6365181B1 (en) 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition
GB0101198D0 (en) 2001-01-17 2001-02-28 Scherer Technologies Inc R P Ingestible compositions containing an odoriferous oil
AUPR510001A0 (en) * 2001-05-18 2001-06-14 Jupitar Pty Ltd Formulation and method
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
NZ536267A (en) * 2002-04-10 2007-06-29 Fred H Miller Multi-phase, multi-compartment and multi-ingredient capsular system
US20050215625A9 (en) * 2003-01-08 2005-09-29 Nesselroad James M Iii Combination therapy for anticoagulation
JP2005075804A (ja) * 2003-09-03 2005-03-24 Toyo Capsule Kk メナテトレノン含有医薬組成物
WO2005089716A1 (fr) * 2004-03-24 2005-09-29 Takeda Pharmaceutical Company Limited Préparation en teneur élevée
WO2006097793A2 (fr) 2004-04-15 2006-09-21 Chiasma, Ltd. Compositions capables de faciliter la penetration a travers une barriere biologique
CA2578903A1 (fr) * 2004-08-31 2006-03-09 Akzo Nobel N.V. Procede de solubilisation de pigments, composition de pigments et utilisation de celle-ci
EP2034853B1 (fr) * 2006-06-27 2012-08-08 Akzo Nobel N.V. Formulations comprenant une vitamine et utilisation de celles-ci pour fabriquer une nourriture pour animaux enrichie et des formulations de soin personnel
CA2702577A1 (fr) 2007-10-15 2009-04-23 Jbs United, Inc. Procede permettant d'accroitre la performance d'une progeniture
WO2009133552A2 (fr) 2008-04-29 2009-11-05 Nikken Sohonsha Corporation Procédés de traitement de troubles ophtalmiques
JP6063615B2 (ja) * 2008-04-29 2017-01-18 株式会社日健総本社 眼の医学的症状の治療用組成物
ES3058497T3 (en) 2008-09-17 2026-03-11 Amryt Endo Inc Pharmaceutical compositions comprising polypeptides and related methods of delivery
US9532963B2 (en) 2009-03-09 2017-01-03 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
US8197871B2 (en) * 2009-05-13 2012-06-12 L Europa Gary A Composition for headache treatment
KR101904388B1 (ko) * 2009-10-23 2018-10-05 프로노바 바이오파마 너지 에이에스 지방산 오일 혼합물의 코팅된 캡슐 및 정제
US10610528B2 (en) * 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US8722131B2 (en) 2010-09-07 2014-05-13 Dsm Nutritional Products Ag Comestible emulsions
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
US8715648B2 (en) 2011-02-16 2014-05-06 Pivotal Therapeutics Inc. Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
EP3157505B1 (fr) 2014-06-17 2019-07-24 Merck Sharp & Dohme B.V. Formulations stables de testostérone undécanoate
PL3253401T3 (pl) 2015-02-03 2025-08-04 Amryt Endo, Inc. Leczenie akromegalii oktreotydem doustnym
KR102678365B1 (ko) * 2018-03-20 2024-06-26 재단법인 경기도경제과학진흥원 콜레칼시페롤의 가용화 조성물 및 그 제조방법
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
DE102021003906B4 (de) 2021-07-30 2023-03-30 Mirco Bienhaus Verfahren und Vorrichtungen zur Herstellung fester oder halbfester Arzneiformen mit einem mehrschichtigen Aufbau

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5665820A (en) * 1979-11-02 1981-06-03 Eisai Co Ltd Hard capsule with high content of tocopherol nicotinate
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
AU561367B2 (en) * 1983-05-02 1987-05-07 Scherer, R.P. Pty. Ltd. Vitamin composition with enhanced bioavailability
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
JPH01233218A (ja) * 1988-03-15 1989-09-19 Daikyo Yakuhin Kogyo Kk ビタミン組成物
US5188688A (en) * 1990-07-20 1993-02-23 Minnesota Mining And Manufacturing Company Method of sealing a gelatin capsule
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations

Also Published As

Publication number Publication date
DE69013923D1 (de) 1994-12-08
HK85196A (en) 1996-05-24
US5738871A (en) 1998-04-14
FI920646A7 (fi) 1992-02-14
FI920646A0 (fi) 1992-02-14
CA2063791C (fr) 2000-12-19
EP0487575A1 (fr) 1992-06-03
NO920604D0 (no) 1992-02-14
WO1991002520A1 (fr) 1991-03-07
NO302333B1 (no) 1998-02-23
ES2062543T3 (es) 1994-12-16
AU6161990A (en) 1991-04-03
EP0487575B1 (fr) 1994-11-02
JPH04507418A (ja) 1992-12-24
ATE113471T1 (de) 1994-11-15
NO920604L (no) 1992-02-14
AU633959B2 (en) 1993-02-11
DE69013923T2 (de) 1995-03-16
CA2063791A1 (fr) 1991-02-18

Similar Documents

Publication Publication Date Title
DE69013923D1 (de) Arzneiformulierungen.
ZA966067B (en) New pharmaceutical dosage formulations of fenofibrate and their applications
CO4761073A1 (es) Preparados que contienen ciclosporina
ES2052645T3 (es) Acidos poliinsaturados con accion vasocinetica y formulaciones farmaceuticas y cosmeticas que los contienen.
DE69720787D1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
ES534598A0 (es) Un procedimiento para preparar una solucion acuosa que contiene una sustancia farmaceutica soluble en lipidos
CO4970836A1 (es) Formulaciones inyectables de larga accion que contienen aceite de castor hidrogenado
MXPA01013210A (es) Composiciones farmaceuticas y nutricionales que contienen acidos grasos esenciales y agentes que disminuyen en la homocisteina.
AR004483A1 (es) Compuestos para uso en terapia que comprenden un residuo de 1,3-propano diol como agente enlazante entre el residuo de ácido graso y un residuo bioactivo, usos de dichos compuestos y medicamentos , alimentos y formulaciones para el cuidado o tratamiento de la piel que comprenden a dichos compuestos
NO940277L (no) Triglycerider og blandinger av slike
ES2191979T3 (es) Sistema de administracion de acido linoleico conjugado en preparaciones cosmeticas.
HRP20010615B1 (hr) Farmaceutski pripravak koji sadržava inhibitore protonske pumpe
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
KR960702304A (ko) 고용량 제형 (High dose formulations)
MY104412A (en) Acne treatment.
GR3001312T3 (en) Pharmaceutical composition containing 2-(2-fluoro-4-biphenylyl)propionic acid or a salt thereof
YU17899A (sh) Farmaceutske mikrosfere valproinske kiseline za oralnu upotrebu
PT697814E (pt) Formulacoes para verter que contem material polimerico glicois e gliceridos
DK206387D0 (da) Anvendelse af glucofurol til flydende-goeren af laegemiddelpraeparater til fyldning i bloede gelatinkapsler
IL86395A (en) Pharmaceutical compositions with improved bioavailability containing flunarizine and polyethoxylated castor oil
AR002759A1 (es) Composiciones farmaceuticas en dosis unitarias, que incluyen inhibidores de proteinasa.
NO891220L (no) Middel som inneholder salicylsyre for behandling av lepidose.
AR016629A1 (es) Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica.
CO4970832A1 (es) Nuevas formulaciones y procesos para su fabricacion
JPS5764609A (en) Cyclophosphamide composition for rectal administration